Randomized Controlled Trial
Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast...
J. Clin. Oncol. 1997 Sep 1; 15 (9): 3149-55.
Clinical Trial
Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.
J. Clin. Oncol. 1995 Dec 1; 13 (12): 2886-94.
Clinical Trial
Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.
J. Clin. Oncol. 1996 Jan 1; 14 (1): 58-65.